cbdMD Statistics
Total Valuation
cbdMD has a market cap or net worth of $1.99 million. The enterprise value is $811,536.
Important Dates
The last earnings date was Wednesday, December 18, 2024, after market close.
| Earnings Date | Dec 18, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
cbdMD has 5.54 million shares outstanding. The number of shares has increased by 113.25% in one year.
| Current Share Class | 5.54M |
| Shares Outstanding | 5.54M |
| Shares Change (YoY) | +113.25% |
| Shares Change (QoQ) | +82.70% |
| Owned by Insiders (%) | 8.87% |
| Owned by Institutions (%) | 3.45% |
| Float | 5.05M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.08 |
| Forward PS | 0.09 |
| PB Ratio | 0.72 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.04 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.74, with a Debt / Equity ratio of 0.65.
| Current Ratio | 0.74 |
| Quick Ratio | 0.40 |
| Debt / Equity | 0.65 |
| Debt / EBITDA | 2.48 |
| Debt / FCF | n/a |
| Interest Coverage | -112.36 |
Financial Efficiency
Return on equity (ROE) is -67.31% and return on invested capital (ROIC) is -25.99%.
| Return on Equity (ROE) | -67.31% |
| Return on Assets (ROA) | -15.48% |
| Return on Capital (ROIC) | -25.99% |
| Revenue Per Employee | $374,657 |
| Profits Per Employee | -$148,156 |
| Employee Count | 52 |
| Asset Turnover | 1.46 |
| Inventory Turnover | 2.22 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -44.38% in the last 52 weeks. The beta is 2.01, so cbdMD's price volatility has been higher than the market average.
| Beta (5Y) | 2.01 |
| 52-Week Price Change | -44.38% |
| 50-Day Moving Average | 0.46 |
| 200-Day Moving Average | 0.61 |
| Relative Strength Index (RSI) | 37.96 |
| Average Volume (20 Days) | 791,149 |
Short Selling Information
The latest short interest is 193,152, so 3.49% of the outstanding shares have been sold short.
| Short Interest | 193,152 |
| Short Previous Month | 280,762 |
| Short % of Shares Out | 3.49% |
| Short % of Float | 3.83% |
| Short Ratio (days to cover) | 1.14 |
Income Statement
In the last 12 months, cbdMD had revenue of $19.48 million and -$7.70 million in losses. Loss per share was -$1.79.
| Revenue | 19.48M |
| Gross Profit | 12.00M |
| Operating Income | -3.32M |
| Pretax Income | -21.65M |
| Net Income | -7.70M |
| EBITDA | -2.17M |
| EBIT | -3.32M |
| Loss Per Share | -$1.79 |
Full Income StatementBalance Sheet
The company has $2.45 million in cash and $1.27 million in debt, giving a net cash position of $1.18 million or $0.21 per share.
| Cash & Cash Equivalents | 2.45M |
| Total Debt | 1.27M |
| Net Cash | 1.18M |
| Net Cash Per Share | $0.21 |
| Equity (Book Value) | 1.96M |
| Book Value Per Share | 0.50 |
| Working Capital | -2.23M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$352,792 and capital expenditures -$190,015, giving a free cash flow of -$542,807.
| Operating Cash Flow | -352,792 |
| Capital Expenditures | -190,015 |
| Free Cash Flow | -542,807 |
| FCF Per Share | -$0.10 |
Full Cash Flow StatementMargins
Gross margin is 61.57%, with operating and profit margins of -17.02% and -18.99%.
| Gross Margin | 61.57% |
| Operating Margin | -17.02% |
| Pretax Margin | -18.99% |
| Profit Margin | -18.99% |
| EBITDA Margin | -11.12% |
| EBIT Margin | -17.02% |
| FCF Margin | n/a |